查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032395

獸用疫苗市場報告：按疫苗類型、技術、給藥途徑、分銷管道和地區分類（2026-2034 年）

Veterinary Vaccines Market Report by Vaccine Type, Technology, Route of Administration, Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球動物疫苗市場規模達158億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到307億美元，2026年至2034年的複合年成長率（CAGR）為7.41%。市場成長的主要驅動力是人們對獸醫學的日益關注、對牲畜保險的需求以及新型獸用疫苗的上市。目前，北美市場佔據主導地位，這得益於該地區寵物飼養家庭數量的成長、先進的醫療保健基礎設施以及大規模的畜牧業。

獸用疫苗是用於家畜和野生動物的生物製藥，可透過注射或口服給藥。它們能刺激身體產生保護性免疫反應，而不會引起疾病本身。常見的獸用疫苗包括去活化疫苗、減毒活病毒疫苗和重組疫苗。這些疫苗有助於減輕動物的痛苦，增強免疫力，並預防各種通用感染疾病的發生和傳播。

獸用疫苗市場趨勢：

人們對獸醫保健的興趣日益濃厚

根據研究報告，2023年全球獸醫保健市場規模達433億美元。隨著寵物飼養人數的增加，人們對寵物健康的關注度也日益提高，導致寵物就診量和預防性治療需求增加。疫苗接種是維護寵物健康的關鍵環節，推動了獸用疫苗的需求成長。大眾日益認知到預防動物疾病（而不僅僅是治療疾病）的重要性，這為獸用疫苗市場帶來了良好的發展前景。

疫苗接種是一種高效的預防措施，已成為寵物和牲畜醫療保健計劃中不可或缺的一部分。寵物飼主和牲畜養殖戶都願意為包括疫苗接種在內的醫療保健費用支付更多，以預防可能損害動物健康和生產力的疾病。隨著獸醫服務日益普及，這一趨勢正在推動對各種疫苗的需求。

牲畜保險需求不斷成長

根據這份研究報告，2023年全球畜牧業保險市場規模達36億美元。許多畜牧業保險保單要求牲畜接種常見疾病疫苗作為承保條件。投保的農民和牲畜所有者被鼓勵為牲畜接種疫苗以履行合約義務，這積極影響了獸用疫苗的市場佔有率。

牲畜保險通常用於降低因疾病、意外或自然災害造成的牲畜損失所帶來的經濟風險。為牲畜接種疫苗的農民可以降低疾病爆發的風險，從而提高牲畜的投保率並降低理賠的可能性。這鼓勵了定期接種疫苗，並增加了疫苗需求。

新產品發布

為了應對新出現的動物疾病和新發現的病原體，新型動物疫苗正在研發中。先前未知和新出現的疾病發病率的不斷上升，推動了對新型疫苗的需求，進而促進了動物疫苗市場的成長。新一代疫苗，例如重組疫苗、DNA疫苗和載體疫苗，提高了預防動物疾病的有效性和安全性。這些新型疫苗通常更有效、副作用更少，並且能提供更持久的免疫力，因此對獸醫和寵物飼主更具吸引力。許多新產品只需一劑即可預防多種疾病或病毒株，從而減輕了獸醫和飼主的負擔。

本報告解答的主要問題：

  • 全球獸用疫苗市場迄今為止的發展趨勢是什麼？您預計未來幾年該市場將如何發展？
  • 新冠疫情對全球動物疫苗市場產生了哪些影響？
  • 主要區域市場有哪些？
  • 按疫苗類型分類的市場組成是什麼？
  • 市場按技術分類是怎樣的？
  • 依給藥途徑分類的市場區隔如何？
  • 按分銷管道分類的市場區隔如何？
  • 該產業價值鏈包含哪些不同階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球動物疫苗市場的結構是怎麼樣的？主要參與者有哪些？
  • 這個行業的競爭有多激烈？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球獸用疫苗市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依疫苗類型分類

  • 牲畜疫苗
    • 主要部分
      • 牛疫苗
      • 家禽疫苗
      • 豬疫苗
      • 其他
  • 伴侶動物疫苗
    • 主要部分
      • 犬用疫苗
      • 貓疫苗
      • 馬疫苗

第7章 市場區隔：依技術分類

  • 減毒活病毒疫苗
  • 去活化疫苗
  • 類毒素疫苗
  • 重組疫苗
  • 其他

第8章 市場區隔：依給藥途徑

  • 皮下
  • 肌肉內部
  • 鼻內

第9章 市場區隔：依分銷通路分類

  • 動物醫院
  • 動物診所
  • 藥局/藥局
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Elanco Animal Health Incorporated
    • Hester Biosciences Limited
    • HIPRA
    • Indian Immunologicals Limited
    • Merck & Co. Inc.
    • Neogen Corporation
    • Phibro Animal Health Corporation
    • Virbac SA
    • Zoetis Inc.
Product Code: SR112026A6493

The global veterinary vaccines market size reached USD 15.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 30.7 Billion by 2034, exhibiting a growth rate (CAGR) of 7.41% during 2026-2034. The market is driven primarily because of the growing focus on veterinary healthcare, need for livestock insurance and the launch of new veterinary vaccinations. At present, North America dominates the market because of the rising number of pet parents, advanced veterinary healthcare infrastructure, and significant livestock industry.

Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases.

Veterinary Vaccines Market Trends:

Growing focus on veterinary healthcare

According to The research's report, the global veterinary healthcare market reached USD 43.3 Billion in 2023. As more individuals are becoming pet parents, there is a greater emphasis on their well-being, resulting in increased veterinary appointments and preventive treatment. Vaccinations are an important aspect of keeping pets healthy, which is driving the demand for veterinary vaccinations. The growing awareness among the masses about the necessity of preventing animal diseases rather than simply treating them is offering a favorable veterinary vaccines market outlook.

Vaccination is a very efficient preventive measure, making it an essential component of veterinary healthcare regimens for both companion animals and cattle. Pet parents and livestock producers are willing to pay more on healthcare, including vaccines, to prevent diseases that could harm animal health and productivity. This tendency is catalyzing the demand for a wide variety of immunizations, particularly as veterinary services become more accessible.

Increasing demand for livestock insurance

The research's report shows that the global livestock insurance market reached USD 3.6 Billion in 2023. Many livestock insurance policies demand vaccinations against common diseases as a condition of coverage. Insured farmers and livestock owners are incentivized to vaccinate their animals to meet policy obligations, which is positively influencing the veterinary vaccines market share.

Livestock insurance is generally used to reduce the financial risks connected with livestock loss caused by disease, accidents, or natural catastrophes. Farmers who vaccinate their animals lessen the chance of disease outbreaks, making their livestock more insurable and lowering the possibility of claims. This encourages regular vaccinations, which increases vaccine demand.

New launches

New veterinary vaccinations are being produced to combat developing diseases and newly discovered pathogens impacting animals. As outbreaks of previously unknown or developing illnesses are arising, the demand for novel vaccines is rising, thereby propelling veterinary vaccines market growth. Next-generation vaccines, such as recombinant, DNA, and vector-based vaccinations, improve the efficacy and safety of disease prevention in animals. These new vaccines are frequently more effective, have fewer side effects, and give longer-lasting protection, making them more appealing to physicians and pet owners. New releases frequently feature vaccines that cover many diseases or strains in a single shot, making life easier for vets and owners.

Key Market Segmentation:

The research provides an analysis of the key trends in each segment of the global market, along with veterinary vaccines market forecasts at the global, regional, and country levels from 2026-2034. Our report has categorized the market based on vaccine type, technology, route of administration and distribution channel.

Breakup by Vaccine Type:

  • Livestock Vaccines
  • Bovine Vaccines
  • Poultry Vaccines
  • Porcine Vaccines
  • Others
  • Companion Animal Vaccines
  • Canine Vaccines
  • Feline Vaccines
  • Equine Vaccine.

Breakup by Technology:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Other.

Breakup by Route of Administration:

  • Subcutaneous
  • Intramuscular
  • Intranasa.

Breakup by Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores
  • Other.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Afric.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global veterinary vaccines market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA
  • Indian Immunologicals Limited
  • Merck & Co. Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Virbac SA
  • Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global veterinary vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global veterinary vaccines market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Livestock Vaccines
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Bovine Vaccines
      • 6.1.2.2 Poultry Vaccines
      • 6.1.2.3 Porcine Vaccines
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Companion Animal Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Canine Vaccines
      • 6.2.2.2 Feline Vaccines
      • 6.2.2.3 Equine Vaccines
    • 6.2.3 Market Forecast

7 Market Breakup by Technology

  • 7.1 Attenuated Live Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Inactivated Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Toxoid Vaccines
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Recombinant Vaccines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Subcutaneous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Intranasal
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Veterinary Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmacies and Drug Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Boehringer Ingelheim International GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Ceva Sante Animale
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Elanco Animal Health Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Hester Biosciences Limited
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 HIPRA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Indian Immunologicals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Neogen Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Phibro Animal Health Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Virbac SA
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Zoetis Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials

List of Figures

  • Figure 1: Global: Veterinary Vaccines Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Veterinary Vaccines Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 3: Global: Veterinary Vaccines Market: Breakup by Vaccine Type (in %), 2025
  • Figure 4: Global: Veterinary Vaccines Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Veterinary Vaccines Market: Breakup by Route of Administration (in %), 2025
  • Figure 6: Global: Veterinary Vaccines Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Veterinary Vaccines Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Veterinary Vaccines (Livestock Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Veterinary Vaccines (Livestock Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Veterinary Vaccines (Companion Animal Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Veterinary Vaccines (Companion Animal Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Veterinary Vaccines (Inactivated Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Veterinary Vaccines (Inactivated Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Veterinary Vaccines (Toxoid Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Veterinary Vaccines (Toxoid Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Veterinary Vaccines (Recombinant Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Veterinary Vaccines (Recombinant Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Veterinary Vaccines (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Veterinary Vaccines (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Veterinary Vaccines (Subcutaneous) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Veterinary Vaccines (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Veterinary Vaccines (Intramuscular) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Veterinary Vaccines (Intramuscular) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Veterinary Vaccines (Intranasal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Veterinary Vaccines (Intranasal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Veterinary Vaccines (Veterinary Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Veterinary Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Veterinary Vaccines (Veterinary Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Veterinary Vaccines (Veterinary Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Veterinary Vaccines (Other Distribution Channels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Veterinary Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: North America: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: North America: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: United States: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: United States: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Canada: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Canada: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Asia-Pacific: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Asia-Pacific: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: China: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: China: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Japan: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Japan: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: India: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: India: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: South Korea: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: South Korea: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Australia: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Australia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Indonesia: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Indonesia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Europe: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Europe: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Germany: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Germany: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: France: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: France: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: United Kingdom: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: United Kingdom: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Italy: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Italy: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Spain: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Spain: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Russia: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Russia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Latin America: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Latin America: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Brazil: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Brazil: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Mexico: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Mexico: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Middle East and Africa: Veterinary Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Middle East and Africa: Veterinary Vaccines Market: Breakup by Country (in %), 2025
  • Figure 84: Middle East and Africa: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Global: Veterinary Vaccines Industry: SWOT Analysis
  • Figure 86: Global: Veterinary Vaccines Industry: Value Chain Analysis
  • Figure 87: Global: Veterinary Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Veterinary Vaccines Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Veterinary Vaccines Market Forecast: Breakup by Vaccine Type (in Million USD), 2026-2034
  • Table 3: Global: Veterinary Vaccines Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Veterinary Vaccines Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 5: Global: Veterinary Vaccines Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 6: Global: Veterinary Vaccines Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Veterinary Vaccines Market: Competitive Structure
  • Table 8: Global: Veterinary Vaccines Market: Key Players